Sanofi SA to Discuss Phase 2b Results Of The Investigational BTK Inhibitor ('168) In Relapsing Multiple Sclerosis Conference Call - Final.
In: Fair Disclosure Wire, 2020-04-23
transcript
Zugriff:
Titel: |
Sanofi SA to Discuss Phase 2b Results Of The Investigational BTK Inhibitor ('168) In Relapsing Multiple Sclerosis Conference Call - Final.
|
---|---|
Zeitschrift: | Fair Disclosure Wire, 2020-04-23 |
Veröffentlichung: | 2020 |
Medientyp: | transcript |
Sonstiges: |
|